Evaluation of Extended and Continuous Use Oral Contraceptives

Overview

Journal Ther Clin Risk Manag

Publisher Dove Medical Press

Date 2009 Feb 12

PMID 19209272

Citations 13

Authors

Kristen Page Wright

Julia V Johnson

Affiliations

Soon will be listed here.

Abstract

Oral contraceptives are classically given in a cyclic manner with 21 days of active pills followed by 7 days of placebo. In the past 4 years, new oral contraceptives have been introduced which either shorten the placebo time, lengthen the active pills (extended cycle), or provide active pills every day (continuous). These concepts are not new; extended and continuous pills were first studied in the 1960s and 1970s and have been provided in an off-label manner by gynecologists to treat menstrual disorders, such as menorrhagia and dysmenorrhea, and gynecologic disorders, such as endometriosis. Now that extended and continuous combined oral contraceptives are available for all patients, it is critical for providers to understand the physiology, dosing, side effects, and benefits of this form of oral contraceptive. This article reviews the history and the potential uses of the new continuous combined oral contraceptive.

Citing Articles

Development of breakthrough bleeding model of combined-oral contraceptives utilizing model-based meta-analysis.

Chen H, Chun D, Lingineni K, Guzy S, Cristofoletti R, Hoechel J CPT Pharmacometrics Syst Pharmacol. 2024; 13(11):2016-2025.

PMID: 39551952 PMC: 11578130. DOI: 10.1002/psp4.13261.

The Menstrual Health Manager (MHM): A Resource to Reduce Discrepancies Between Science and Practice in Sport and Exercise.

Badenhorst C Sports Med. 2024; 54(11):2725-2741.

PMID: 38904920 PMC: 11561008. DOI: 10.1007/s40279-024-02061-w.

Experts' view on the role of oestrogens in combined oral contraceptives: emphasis on oestetrol (E4).

Creinin M, Cagnacci A, Spaczynski R, Stute P, Chabbert-Buffet N, Korver T Front Glob Womens Health. 2024; 5:1395863.

PMID: 38655395 PMC: 11035732. DOI: 10.3389/fgwh.2024.1395863.

Lower levels of the neuroprotective tryptophan metabolite, kynurenic acid, in users of estrogen contraceptives.

Bjorke-Monsen A, Varsi K, Sakkestad S, Ulvik A, Ebbing C, Ueland P Sci Rep. 2023; 13(1):16370.

PMID: 37773439 PMC: 10541439. DOI: 10.1038/s41598-023-43196-6.

Management of a Patient With Premenstrual Syndrome Using Acupuncture, Supplements, and Meditation: A Case Report.

Martin B, Woodruff J J Chiropr Med. 2023; 22(3):222-229.

PMID: 37644997 PMC: 10461168. DOI: 10.1016/j.jcm.2023.03.006.

References

Sitruk-Ware R . New progestagens for contraceptive use. Hum Reprod Update. 2005; 12(2):169-78. DOI: 10.1093/humupd/dmi046. View

Cachrimanidou A, Hellberg D, Nilsson S, von Schoulz B, Crona N, Siegbahn A . Hemostasis profile and lipid metabolism with long-interval use of a desogestrel-containing oral contraceptive. Contraception. 1994; 50(2):153-65. DOI: 10.1016/0010-7824(94)90051-5. View

Rossmanith W, Steffens D, Schramm G . A comparative randomized trial on the impact of two low-dose oral contraceptives on ovarian activity, cervical permeability, and endometrial receptivity. Contraception. 1997; 56(1):23-30. DOI: 10.1016/s0010-7824(97)00070-x. View

Speroff L, DeCherney A . Evaluation of a new generation of oral contraceptives. The Advisory Board for the New Progestins. Obstet Gynecol. 1993; 81(6):1034-47. View

Edelman A, Lew R, Cwiak C, Nichols M, Jensen J . Acceptability of contraceptive-induced amenorrhea in a racially diverse group of US women. Contraception. 2007; 75(6):450-3. DOI: 10.1016/j.contraception.2007.02.005. View

Gerschultz K, Sucato G, Hennon T, Murray P, Gold M . Extended cycling of combined hormonal contraceptives in adolescents: physician views and prescribing practices. J Adolesc Health. 2007; 40(2):151-7. DOI: 10.1016/j.jadohealth.2006.09.013. View

Wiegratz I, Hommel H, Zimmermann T, Kuhl H . Attitude of German women and gynecologists towards long-cycle treatment with oral contraceptives. Contraception. 2004; 69(1):37-42. DOI: 10.1016/j.contraception.2003.09.004. View

Cachrimanidou A, Hellberg D, Nilsson S, Waldenstrom U, OLSSON S, Sikstrom B . Long-interval treatment regimen with a desogestrel-containing oral contraceptive. Contraception. 1993; 48(3):205-16. DOI: 10.1016/0010-7824(93)80141-h. View

Schneider M, Fisher M, FRIEDMAN S, Bijur P, Toffler A . Menstrual and premenstrual issues in female military cadets: a unique population with significant concerns. J Pediatr Adolesc Gynecol. 1999; 12(4):195-201. DOI: 10.1016/s1083-3188(99)00025-x. View

10.

Davis A, Kroll R, Soltes B, Zhang N, Grubb G, Constantine G . Occurrence of menses or pregnancy after cessation of a continuous oral contraceptive. Fertil Steril. 2007; 89(5):1059-1063. DOI: 10.1016/j.fertnstert.2007.05.012. View

11.

Kwiecien M, Edelman A, Nichols M, Jensen J . Bleeding patterns and patient acceptability of standard or continuous dosing regimens of a low-dose oral contraceptive: a randomized trial. Contraception. 2003; 67(1):9-13. DOI: 10.1016/s0010-7824(02)00445-6. View

12.

Den Tonkelaar I, Oddens B . Preferred frequency and characteristics of menstrual bleeding in relation to reproductive status, oral contraceptive use, and hormone replacement therapy use. Contraception. 1999; 59(6):357-62. DOI: 10.1016/s0010-7824(99)00043-8. View

13.

Coutinho E, ODwyer E, Barbosa I, Gu Z, Shaaban M, Abdel Aleem H . Comparative study on intermittent versus continuous use of a contraceptive pill administered by vaginal route. Contraception. 1995; 51(6):355-8. DOI: 10.1016/0010-7824(95)00101-f. View

14.

Sulak P, Cressman B, WALDROP E, Holleman S, Kuehl T . Extending the duration of active oral contraceptive pills to manage hormone withdrawal symptoms. Obstet Gynecol. 1997; 89(2):179-83. DOI: 10.1016/S0029-7844(96)00488-7. View

15.

Mahmood T, Saridogan E, Smutna S, Habib A, Djahanbakhch O . The effect of ovarian steroids on epithelial ciliary beat frequency in the human Fallopian tube. Hum Reprod. 1998; 13(11):2991-4. DOI: 10.1093/humrep/13.11.2991. View

16.

Anderson F, Hait H . A multicenter, randomized study of an extended cycle oral contraceptive. Contraception. 2003; 68(2):89-96. DOI: 10.1016/s0010-7824(03)00141-0. View

17.

Edelman A, Koontz S, Nichols M, Jensen J . Continuous oral contraceptives: are bleeding patterns dependent on the hormones given?. Obstet Gynecol. 2006; 107(3):657-65. DOI: 10.1097/01.AOG.0000199950.64545.16. View

18.

Kjerulff K, Erickson B, Langenberg P . Chronic gynecological conditions reported by US women: findings from the National Health Interview Survey, 1984 to 1992. Am J Public Health. 1996; 86(2):195-9. PMC: 1380327. DOI: 10.2105/ajph.86.2.195. View

19.

Barnhart K, Mirkin S, Grubb G, Constantine G . Return to fertility after cessation of a continuous oral contraceptive. Fertil Steril. 2008; 91(5):1654-6. DOI: 10.1016/j.fertnstert.2008.02.122. View

20.

Trego L . Military women's menstrual experiences and interest in menstrual suppression during deployment. J Obstet Gynecol Neonatal Nurs. 2007; 36(4):342-7. DOI: 10.1111/j.1552-6909.2007.00166.x. View